These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 26384286

  • 1. Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect.
    Kharbanda C, Alam MS, Hamid H, Javed K, Dhulap A, Bano S, Ali Y.
    Bioorg Med Chem Lett; 2015 Oct 15; 25(20):4601-5. PubMed ID: 26384286
    [Abstract] [Full Text] [Related]

  • 2. Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents.
    Kharbanda C, Alam MS, Hamid H, Javed K, Shafi S, Ali Y, Alam P, Pasha MA, Dhulap A, Bano S, Nazreen S, Haider S.
    Bioorg Med Chem Lett; 2014 Nov 15; 24(22):5298-303. PubMed ID: 25442322
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and evaluation of some new pyrazoline substituted benzenesulfonylureas as potential antiproliferative agents.
    Rathore P, Yaseen S, Ovais S, Bashir R, Yaseen R, Hameed AD, Samim M, Gupta R, Hussain F, Javed K.
    Bioorg Med Chem Lett; 2014 Apr 01; 24(7):1685-91. PubMed ID: 24630557
    [Abstract] [Full Text] [Related]

  • 5. Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression.
    Nazreen S, Alam MS, Hamid H, Yar MS, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Kharbanda C, Ali Y, Pillai KK.
    Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3034-42. PubMed ID: 24890090
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists.
    El-Zahabi MA, Elbendary ER, Bamanie FH, Radwan MF, Ghareib SA, Eissa IH.
    Bioorg Chem; 2019 Oct 15; 91():103115. PubMed ID: 31310882
    [Abstract] [Full Text] [Related]

  • 7. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
    Nazreen S, Alam MS, Hamid H, Shahar Yar M, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Kharbanda C, Ali Y, Pillai K.
    Arch Pharm (Weinheim); 2015 Jun 15; 348(6):421-32. PubMed ID: 25900064
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.
    Nazreen S, Alam MS, Hamid H, Yar MS, Shafi S, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Ali Y, Kharbanda C, Pillai KK.
    Eur J Med Chem; 2014 Nov 24; 87():175-85. PubMed ID: 25255433
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
    Rathish IG, Javed K, Bano S, Ahmad S, Alam MS, Pillai KK.
    Eur J Med Chem; 2009 Jun 24; 44(6):2673-8. PubMed ID: 19171410
    [Abstract] [Full Text] [Related]

  • 10. Novel Piperine Derivatives with Antidiabetic Effect as PPAR-γ Agonists.
    Kharbanda C, Alam MS, Hamid H, Javed K, Bano S, Ali Y, Dhulap A, Alam P, Pasha MA.
    Chem Biol Drug Des; 2016 Sep 24; 88(3):354-62. PubMed ID: 27037532
    [Abstract] [Full Text] [Related]

  • 11. A short series of antidiabetic sulfonylureas exhibit multiple ligand PPARgamma-binding patterns.
    Arrault A, Rocchi S, Picard F, Maurois P, Pirotte B, Vamecq J.
    Biomed Pharmacother; 2009 Jan 24; 63(1):56-62. PubMed ID: 18280694
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis, molecular modelling studies and ADME prediction of benzothiazole clubbed oxadiazole-Mannich bases, and evaluation of their anti-diabetic activity through in vivo model.
    Bhutani R, Pathak DP, Kapoor G, Husain A, Kant R, Iqbal MA.
    Bioorg Chem; 2018 Apr 24; 77():6-15. PubMed ID: 29316509
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents.
    Suaifan GA, Shehadeh MB, Darwish RM, Al-Ijel H, Abbate V.
    Molecules; 2015 Nov 06; 20(11):20063-78. PubMed ID: 26561797
    [Abstract] [Full Text] [Related]

  • 18. Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
    Humphries PS, Bailey S, Almaden JV, Barnum SJ, Carlson TJ, Christie LC, Do QQ, Fraser JD, Hess M, Kellum J, Kim YH, McClellan GA, Ogilvie KM, Simmons BH, Skalitzky D, Sun S, Wilhite D, Zehnder LR.
    Bioorg Med Chem Lett; 2006 Dec 01; 16(23):6120-3. PubMed ID: 16973358
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents.
    Sroor FM, Abbas SY, Basyouni WM, El-Bayouki KAM, El-Mansy MF, Aly HF, Ali SA, Arafa AF, Haroun AA.
    Bioorg Chem; 2019 Nov 01; 92():103290. PubMed ID: 31561109
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.